Monilethrix Cell Models for Research

Monilethrix is a rare autosomal dominant hair disorder characterized by beaded hair shafts that break easily, leading to alopecia. The exact prevalence is unknown, but it is estimated to affect fewer than 1 in 100,000 individuals worldwide. Onset typically occurs in infancy, and severity varies. The condition is not life-threatening but can cause significant psychosocial distress. There is no cure, and treatment options are limited to cosmetic measures and topical agents. Research is needed to understand the molecular mechanisms and develop targeted therapies.

Monilethrix is an ideal model for studying hair follicle biology and keratin function. The disease is primarily caused by mutations in hair keratin genes, providing a clear genotype-phenotype correlation. Public datasets, such as those in ClinVar and UniProt, contain curated information on pathogenic variants. Open questions include the precise role of keratins in hair shaft integrity and the potential for gene therapy or pharmacological chaperones. Gene-edited cell models can help answer these questions by enabling functional studies of specific mutations.

Monilethrix is not a cancer, but it involves defects in intermediate filament formation. The major pathways affected are:

1. Keratin intermediate filament assembly: Mutations in hair keratins disrupt the formation of keratin filaments, leading to structural weakness in the hair shaft.

2. Disulfide bond formation: Keratins contain cysteine residues that form disulfide bonds, contributing to hair strength. Mutations may affect these bonds.

3. Cell-cell adhesion: Keratins interact with desmosomes, and mutations may impair adhesion between hair cortex cells.

These pathways are not oncogenic but are crucial for hair shaft integrity.

Data from ClinVar and literature. Frequencies are approximate among reported cases.

Monilethrix primarily affects structural proteins, but downstream effects may involve signaling pathways related to stress response and apoptosis. Key nodes include:

• • Keratin filaments: Provide mechanical support and regulate stress signaling.
• • Desmosomes: Mediate cell adhesion and signal transduction.
• • MAPK pathway: May be activated in response to cellular stress from filament disruption.
• • PI3K/AKT pathway: Involved in cell survival and proliferation, potentially affected by keratin dysfunction.

These networks are not classic oncogenic pathways but are relevant to hair follicle homeostasis.

Organoids derived from hair follicle stem cells can recapitulate hair follicle structure and are useful for studying keratin mutations. They can be generated from patient-derived cells or gene-edited stem cells.

• • Genetically engineered mouse models (GEMMs) carrying keratin mutations have been developed, but they may not fully recapitulate the human hair phenotype.
• • Patient-derived xenografts (PDX) are not commonly used for non-cancerous hair disorders.
• • Induced models using CRISPR in mice can introduce specific mutations to study their effects on hair formation.

These models are valuable for in vivo validation of gene-edited cell findings.

CRISPR-Cas9 technology enables the creation of isogenic cell lines with specific keratin mutations. For example, a KRT86 knockout cell line can be generated to study loss-of-function effects, while a KRT81 knock-in cell line with a patient-specific mutation can model dominant-negative effects. These models are sequence-verified and can be used for functional assays, drug screening, and mechanistic studies. Commercially available gene-edited cell lines accelerate research by providing consistent, reproducible models without the need for in-house CRISPR expertise.

Knockout and knock-in cell lines are used to validate the function of keratin genes in hair shaft formation. For example, KRT86 knockout cells can be used to assess the impact on filament assembly and cell viability. Knock-in lines with specific mutations can help determine the pathogenicity of variants and their effects on protein structure and function.

Isogenic cell line pairs (wild-type vs. mutant) are ideal for high-throughput screening of compounds that may rescue the mutant phenotype. For instance, drugs that enhance keratin filament stability or promote proper folding could be identified. Resistance to treatments can also be modeled by exposing cells to increasing concentrations of a drug and selecting for resistant clones.

CRISPR-based synthetic lethality screens can identify genes that are essential for survival in the context of keratin mutations. This could reveal novel therapeutic targets. Additionally, gene-edited cells can be used to discover biomarkers for disease progression or response to therapy.